IconOVir Bio
Biotechnology Research
4570 Executive Drive
10 employees
- Employees
- 10
- Contacts
- 3
- Emails
- 3
- Phones
- 2
IconOVir Bio Overview
- Headquarters
- 4570 Executive Drive
- Website
- www.iconovir.com
- Industry
- Biotechnology Research
- Employees
- 10
- Funding
- 77.0M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About IconOVir Bio
IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.
IconOVir Bio Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
IconOVir Bio Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Nicole Van De Leuv | Principal at Two River | San Diego, California, United States |
Email
Phone
|
| Helen S. Kim | Santa Monica, California, United States |
Email
|
|
| Jakob Loven, Phd |
View
|
||
| Mark Mccamish | President & Chief Executive Officer | San Diego, California, United States |
Email
Phone
|
Compare Similar Companies to IconOVir Bio
Arcellx
Biotechnology Research
Adicet Bio, Inc
Biotechnology Research
Latigo Biotherapeutics, Inc.
Biotechnology Research
Imugene Limited
Biotechnology Research
Vida Ventures, LLC
Venture Capital And Private Equity Principals
IMUNON
Biotechnology
Plus Therapeutics, Inc.
Pharmaceutical Manufacturing
Windtree Therapeutics, Inc.
Pharmaceutical Manufacturing
Chimeric Therapeutics
Biotechnology Research
76Bio, Inc.
Biotechnology Research